Cargando…

Immunity after COVID-19 vaccinations in immunocompromised patients with psoriasis

Detalles Bibliográficos
Autor principal:	Boekel, Laura
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2022
Materias:	Comment
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8577226/ https://www.ncbi.nlm.nih.gov/pubmed/34778845 http://dx.doi.org/10.1016/S2665-9913(21)00360-X

Ejemplares similares

Erythrodermic psoriasis after COVID-19 vaccination
por: Trepanowski, Nicole, et al.
Publicado: (2022)

Adverse events after first COVID-19 vaccination in patients with autoimmune diseases
por: Boekel, Laura, et al.
Publicado: (2021)

COVID-19 vaccine acceptance over time in patients with immune-mediated inflammatory rheumatic diseases
por: Boekel, Laura, et al.
Publicado: (2022)

Perspective of patients with autoimmune diseases on COVID-19 vaccination
por: Boekel, Laura, et al.
Publicado: (2021)

Rituximab during the COVID-19 pandemic: time to discuss treatment options with patients
por: Boekel, L, et al.
Publicado: (2022)

COVID-19 vaccination in patients with immunity-mediated kidney disease
por: Prendecki, Maria, et al.
Publicado: (2021)

The elusive goal of COVID-19 vaccine immunity
por: Abu-Raddad, Laith J, et al.
Publicado: (2023)

Hybrid immunity and strategies for COVID-19 vaccination
por: Hui, David S
Publicado: (2023)

Patients with rheumatic diseases adhere to COVID-19 isolation measures more strictly than the general population
por: Hooijberg, Femke, et al.
Publicado: (2020)

Suspending methotrexate for 2 weeks after COVID-19 vaccination
por: Coates, Laura C, et al.
Publicado: (2022)

Pre-exposure anti-SARS-CoV-2 monoclonal antibodies in severely immunocompromised patients with immune-mediated inflammatory diseases
por: Goulenok, Tiphaine, et al.
Publicado: (2022)

Vaccine efficacy and immune interference: co-administering COVID-19 and influenza vaccines
por: Altmann, Daniel M, et al.
Publicado: (2022)

Effectiveness of COVID-19 vaccination in immune-mediated inflammatory diseases
por: Sparks, Jeffrey A, et al.
Publicado: (2022)

COVID-19 vaccine design: the Janus face of immune enhancement
por: Hotez, Peter J., et al.
Publicado: (2020)

COVID-19 vaccines: modes of immune activation and future challenges
por: Teijaro, John R., et al.
Publicado: (2021)

Considerations of hybrid immunity and the future of adolescent COVID-19 vaccination
por: Irving, Stephanie A, et al.
Publicado: (2023)

Myopericarditis after COVID-19 vaccination: unexpected but not unprecedented
por: Ryan, Margaret, et al.
Publicado: (2022)

Flare of rheumatoid arthritis after COVID-19 vaccination
por: Terracina, Katherine A, et al.
Publicado: (2021)

COVID-19 vaccines in patients with cancer
por: Trapani, Dario, et al.
Publicado: (2021)

COVID-19 immunity passports and vaccination certificates: scientific, equitable, and legal challenges
por: Phelan, Alexandra L
Publicado: (2020)

Monitoring and managing SARS-CoV-2 evolution in immunocompromised populations
por: Li, Pengfei, et al.
Publicado: (2022)

Convalescent plasma from people vaccinated after COVID-19 infection
por: Jabal, Kamal Abu, et al.
Publicado: (2021)

COVID-19 vaccines for patients with haematological conditions
por: Sun, Clare, et al.
Publicado: (2021)

COVID-19 vaccination in patients receiving dialysis
por: Wilde, Benjamin, et al.
Publicado: (2021)

After 62 years of regulating immunity, dexamethasone meets COVID-19
por: Cain, Derek W., et al.
Publicado: (2020)

Humoral and cellular immune responses to mRNA COVID-19 vaccines in patients with axial spondyloarthritis treated with adalimumab or secukinumab
por: Smetanova, Jitka, et al.
Publicado: (2022)

Methotrexate and TNF inhibitors affect long-term immunogenicity to COVID-19 vaccination in patients with immune-mediated inflammatory disease
por: Haberman, Rebecca H, et al.
Publicado: (2022)

Hospital admissions due to COVID-19 in Scotland after one dose of vaccine
por: Dean, Natalie
Publicado: (2021)

Adult-onset Still's disease after mRNA COVID-19 vaccine
por: Magliulo, Daniel, et al.
Publicado: (2021)

COVID-19 vaccine hesitancy
por: Dubé, Eve, et al.
Publicado: (2022)

Incentives for COVID-19 vaccination
por: Brewer, Noel T., et al.
Publicado: (2022)

COVID-19 vaccinations for children
por: Mariatulqabtiah, Abdul Razak, et al.
Publicado: (2022)

COVID-19 vaccination in immunocompromised patients
por: Sonani, Bhavin, et al.
Publicado: (2021)

Myocarditis after COVID-19 mRNA vaccination: clinical observations and potential mechanisms
por: Heymans, Stephane, et al.
Publicado: (2021)

An issue of trust—vaccinating Black patients against COVID-19
por: Okorodudu, Dale O, et al.
Publicado: (2021)

Covid-19 vaccine apps should deliver more to patients
por: Dasgupta, Nabarun, et al.
Publicado: (2021)

COVID-19 vaccination in patients with α1-antitrypsin deficiency
por: Yang, Chengliang, et al.
Publicado: (2021)

Do JAK inhibitors affect immune response to COVID-19 vaccination? Data from the MAJIK-SFR Registry
por: Seror, Raphaèle, et al.
Publicado: (2022)

Modelling vaccination strategies for COVID-19
por: Wagner, Caroline E., et al.
Publicado: (2022)

Waning effectiveness of COVID-19 vaccines
por: Chemaitelly, Hiam, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_981j4dbtb6kc9e1jvpgn9d852g